Search

everythinglearnresearchcommunity

for

Search:↓

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Personality traits and anxiety affect hair loss patients' quality of life.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

AB+ blood group is more common in alopecia areata patients.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Male gender and family history predict alopecia areata recurrence.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Alopecia areata treatment varies, with no optimal method established yet.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.